{"id":3219,"date":"2013-08-15T17:26:15","date_gmt":"2013-08-15T14:26:15","guid":{"rendered":"http:\/\/www.ced.org.tr\/?p=3219"},"modified":"2013-08-15T17:26:15","modified_gmt":"2013-08-15T14:26:15","slug":"odeme-kapsami-disindaki-ilaclar-ve-saglik-hakki","status":"publish","type":"post","link":"http:\/\/www.ced.org.tr\/?p=3219","title":{"rendered":"\u00d6deme kapsam\u0131 d\u0131\u015f\u0131ndaki ila\u00e7lar ve sa\u011fl\u0131k hakk\u0131"},"content":{"rendered":"<p style=\"color: #222222; font-family: arial, sans-serif; font-size: 12.800000190734863px;\">sgk\u2019n\u0131n \u00f6deme kapsam\u0131 d\u0131\u015f\u0131nda tuttu\u011fu ila\u00e7lar, bunlar\u0131 kullanmak zorunda olanlar\u0131 ekonomik olarak zorluyor&#8230;<\/p>\n<div style=\"color: #222222; font-family: arial, sans-serif; font-size: 12.800000190734863px;\"><a href=\"http:\/\/www.bianet.org\/yazar\/mustafa-sutlas\" target=\"_blank\" style=\"color: #1155cc;\">mustafa s\u00fctla\u015f<\/a> \u0130stanbul &#8211; B\u0130A Haber Merkezi 15 A\u011fustos 2013,<\/p>\n<\/div>\n<div style=\"color: #222222; font-family: arial, sans-serif; font-size: 12.800000190734863px;\">\n<p>\u00a0<\/p>\n<p>sa\u011fl\u0131k hakk\u0131 ve hasta haklar\u0131 platformu\u2019na ba\u015fvuran bir hastan\u0131n mesaj\u0131nda \u015funlar yaz\u0131l\u0131yd\u0131:<\/p>\n<p><em>\u201cemekli erkek hastay\u0131m, bir psikiyatri uzman\u0131 profes\u00f6r taraf\u0131ndan yaz\u0131lan bir ilac\u0131n bedelini sosyal g\u00fcvenlik kurumu \u00f6demiyor. paras\u0131n\u0131 kendim vererek kullan\u0131yorum.\u00a0 ayl\u0131k tutar\u0131 neredeyse maa\u015f\u0131m\u0131n \u00fc\u00e7te biri. bu durumda ne yapabilirim.\u201d<\/em><\/p>\n<p>art\u0131k bir \u00e7ok insan astar\u0131 y\u00fcz\u00fcnden pahal\u0131ya geldi\u011fi i\u00e7in kulland\u0131\u011f\u0131 ila\u00e7lar\u0131n bedelini ceplerinden \u00f6d\u00fcyor. ama gerekli ilac\u0131n bedeli, burada belirtildi\u011fi gibi, toplam gelirin \u00fc\u00e7te biri olursa ne sa\u011fl\u0131k hakk\u0131 kal\u0131yor, ne hasta hakk\u0131!<\/p>\n<p>bu durumda\u201chasta\u201d ne yaps\u0131n, ilac\u0131n kar\u015f\u0131l\u0131\u011f\u0131n\u0131 sgk \u00f6demiyorsa \u201chekim\u201d ne yaps\u0131n?<\/p>\n<h2><strong>ilac\u0131n de\u011feri<\/strong><\/h2>\n<p>ila\u00e7lar\u0131n kullan\u0131ld\u0131\u011f\u0131 durumlar (endikasyonlar), etkileri, yan etkileri ve kullan\u0131lacak ki\u015filerin \u00f6zellikleri yap\u0131lan bilimsel ara\u015ft\u0131rmalar \u00e7er\u00e7evesinde belirlenir ve ilac\u0131n ruhsat\u0131na eklenir.<\/p>\n<p>hekimlerin g\u00f6revleri aras\u0131nda ila\u00e7lar\u0131n etki mekanizmalar\u0131 ve kullan\u0131m alanlar\u0131n\u0131 s\u00fcrekli olarak ara\u015ft\u0131rmak da vard\u0131r. \u00fcstelik bu hizmet s\u0131ras\u0131nda da ger\u00e7ekle\u015ftirilebilir. ila\u00e7lar\u0131 \u00fcreten \u015firketler ve\u00a0 bilimsel kurumlar uzun y\u0131llar s\u00fcren \u00e7al\u0131\u015fmalar yaparlar. sonu\u00e7lar\u0131 kesinle\u015fince bunlar\u0131 da bildirirler. bu ila\u00e7larla ilgili karar \u2013 onay s\u00fcre\u00e7leri ger\u00e7ekle\u015fir. sonu\u00e7ta hepsi hastalar\u0131n tedavisi ve iyile\u015fmesi i\u00e7indir.<\/p>\n<p>bu ilac\u0131n bedeli, bir heyet raporu varsa, yaln\u0131z belirli bir ya\u015f grubu i\u00e7in sgk taraf\u0131ndan \u00f6deniyor.<\/p>\n<p>ba\u015fvurudan anla\u015f\u0131lan o ki sgk\u2019n\u0131n bedelini \u00f6dedi\u011fi grup d\u0131\u015f\u0131ndakilerin bu ilac\u0131 kullan\u0131m\u0131 i\u00e7in sa\u011fl\u0131k bakanl\u0131\u011f\u0131\u2019na \u00f6zel bir ba\u015fvuru yap\u0131larak gerekli \u201conay\u201d al\u0131nmam\u0131\u015f.<\/p>\n<h2><strong>yanl\u0131\u015flar bir de\u011fil \u00e7ok<\/strong><\/h2>\n<p>hastan\u0131n ifade etti\u011fi ma\u011fduriyetinin nedenleri, sorumlular\u0131 ve yap\u0131lan yanl\u0131\u015flar ne yaz\u0131k ki \u201c\u00e7ok\u201d!<\/p>\n<p>\u201c<strong>ilk yanl\u0131\u015f<\/strong>\u201d bir tedavinin karar\u0131n\u0131, onunla ilgili sorumlulu\u011fu almas\u0131 gereken hekime b\u0131rak\u0131lmamas\u0131 ve ilac\u0131n bedeli \u00fczerinden bir dayatmayla, hekimin mesle\u011fini ve bilgisini \u00f6zg\u00fcr olarak ve hi\u00e7bir bask\u0131 alt\u0131nda olmadan uygulamas\u0131n\u0131 sa\u011flanmamas\u0131.<\/p>\n<p>para kazanman\u0131n sa\u011fl\u0131ktan daha \u00f6nemli hale geldi\u011fi bir sa\u011fl\u0131k hizmet ve finans sisteminde bu yanl\u0131\u015f hem yap\u0131l\u0131yor, hem kabul g\u00f6r\u00fcyor, hem de kimsenin itiraz\u0131 s\u00f6z konusu olmuyor, ne yaz\u0131k ki!<\/p>\n<p>bir hekim hastas\u0131n\u0131n iyili\u011fi d\u0131\u015f\u0131nda bir ama\u00e7la bir ilac\u0131 re\u00e7etelemesi ya da b\u00f6yle bir olas\u0131l\u0131\u011f\u0131n akla geliyor olmas\u0131\u00a0<strong>\u201cikinci b\u00fcy\u00fck yanl\u0131\u015f\u201d<\/strong>.<\/p>\n<p>dahas\u0131 bunun sorgulanmamas\u0131 da yanl\u0131\u015f\u0131 b\u00fcy\u00fctt\u00fc\u011f\u00fc gibi, kontrol ve denetim sisteminin sorumlular\u0131n\u0131n da bu yanl\u0131\u015fa kat\u0131lm\u0131\u015f olduklar\u0131n\u0131 g\u00f6steriyor<\/p>\n<p>yanl\u0131\u015flar\u0131n bir di\u011feri, bir ilac\u0131n kullan\u0131m alan\u0131n\u0131n geni\u015fletmeye y\u00f6nelik ara\u015ft\u0131rmalar\u0131n, ilac\u0131n \u00fcreticisi taraf\u0131ndan de\u011fil de \u201cortak kamu kaynaklar\u0131\u201dndan finanse etmeye \u00e7al\u0131\u015f\u0131lmas\u0131.<\/p>\n<p>oysa bunun da kurallar\u0131 belli ve hem uygulanmas\u0131, hem de izlenmesi ve denetimi devletin g\u00f6revi.<\/p>\n<p>t\u00fcm bunlardan \u00e7ok daha \u00f6nemli bir ba\u015fka yanl\u0131\u015f ise hastan\u0131n tan\u0131 ve tedavi s\u00fcreciyle ilgili olarak yeterince ve etkin bir \u015fekilde bilgilendirilmemesi,\u00a0<strong>ayd\u0131nlat\u0131lm\u0131\u015f onam\u0131<\/strong>n\u0131n al\u0131nmamas\u0131.<\/p>\n<p>oysa hasta, hekim ve devlet ayn\u0131 yanda durmal\u0131 ve sorunlar\u0131n \u00fczerine hep birlikte gitmeli.<\/p>\n<h2><strong>kurban, ma\u011fdur ve sorumlusu&#8230;<\/strong><\/h2>\n<p>sonu\u00e7ta ortaya \u00e7\u0131kan b\u00fcy\u00fck yanl\u0131\u015f\u0131n kurban\u0131 ise en u\u00e7taki, en zay\u0131f, en \u00e7ok ve en olumsuz etkilenen, ancak ger\u00e7ekleri en az bilen ve sesi en k\u0131s\u0131k \u015fekilde \u00e7\u0131kan hasta ve yak\u0131n\u0131 oluyor.<\/p>\n<p>sa\u011fl\u0131\u011fa ve sa\u011fl\u0131k hizmetine\u00a0<strong>hak temelli bak\u0131\u015f ve yakla\u015f\u0131m<\/strong>, hizmetin bu temelde sunulmas\u0131 zorunlulu\u011fu b\u00f6yle kurbanlar\u0131n hi\u00e7 ortaya \u00e7\u0131kmamas\u0131, ma\u011fduriyetlerin ya\u015fanmamas\u0131 i\u00e7in gerekli.<\/p>\n<p>ama mevcut sa\u011fl\u0131k y\u00f6neticileri ifade etti\u011fimiz bu hak temelli hizmeti savunmak ve uygulamak bir yana, dillerinden d\u00fc\u015f\u00fcrmedikleri \u201ctanr\u0131ya inan\u00e7lar\u0131n\u0131n gere\u011fini\u201d bile yerine getirmeyerek, insanlar\u0131n ac\u0131 ve s\u0131k\u0131nt\u0131 \u00e7ekmelerine, iyi olacaklar\u0131 varsa bile iyi olmamalar\u0131na yol a\u00e7\u0131yorlar.<\/p>\n<p>yanl\u0131\u015flar\u0131n\u0131 ortaya koyarak ele\u015ftirsek de, bu ger\u00e7ekler de\u011fi\u015fmiyor. \u00e7\u00fcnk\u00fc ama\u00e7 insanlar\u0131n sa\u011fl\u0131\u011f\u0131 ve her zaman iyi k\u0131l\u0131nmas\u0131 de\u011fil. \u00e7\u00fcnk\u00fc ama\u00e7 devletin insanlar\u0131n sa\u011fl\u0131\u011f\u0131 i\u00e7in gereken her \u015feyi yapmas\u0131 de\u011fil. bunlar\u0131n tam tersi: \u201cama\u00e7 birilerinin daha \u00e7ok kazanmas\u0131, \u2018sa\u011fl\u0131k\u2019 \u00e7er\u00e7evesinde d\u00f6nen paran\u0131n artmas\u0131, sermayenin sermayesini b\u00fcy\u00fctmesi ve birilerinin de bundan \u2018kendi pay\u2019lar\u0131n\u0131 almas\u0131.<\/p>\n<p>yine de g\u00f6stermek, anlatmak, bilgilendirmek ve \u0131srarla m\u00fccadele etmekten ba\u015fka \u00e7are yok.<\/p>\n<p>yapt\u0131\u011f\u0131m\u0131z da bu i\u015fte!.. (ms\/hk<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>sgk\u2019n\u0131n \u00f6deme kapsam\u0131 d\u0131\u015f\u0131nda tuttu\u011fu ila\u00e7lar, bunlar\u0131 kullanmak zorunda olanlar\u0131 ekonomik olarak zorluyor&#8230; mustafa s\u00fctla\u015f \u0130stanbul &#8211; B\u0130A Haber Merkezi&#46;&#46;&#46;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[63],"tags":[],"class_list":["post-3219","post","type-post","status-publish","format-standard","hentry","category-basinda-saglik"],"aioseo_notices":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[],"_links":{"self":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts\/3219","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3219"}],"version-history":[{"count":0,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts\/3219\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3219"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3219"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3219"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}